News

Sampre Nutritions Limited announced that its board of directors approved the allotment of 1,770,710 fully paid-up equity shares with a face value of Rs 5 each at an issue price of Rs 42 each, including a premium of Rs 37 each, aggregating to Rs 7,43,69,820, to Brahma Gurbani and Meera Gurbani, upon conversion of unsecured loan.

Sampre Nutritions announced that the 35th Annual General Meeting(AGM) of the company will be held on 4 September 2026.

Net profit of Sampre Nutritions declined 1.41% to Rs 0.70 crore in the quarter ended June 2026 as against Rs 0.71 crore during the previous quarter ended June 2025. Sales rose 36.61% to Rs 14.85 crore in the quarter ended June 2026 as against Rs 10.87 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales14.8510.87 37 OPM %10.1012.70 - PBDT1.311.10 19 PBT0.800.71 13 NP0.700.71 -1 Powered by Capital Market - Live News

Sampre Nutritions will hold a meeting of the Board of Directors of the Company on 5 August 2026.

Net profit of Sampre Nutritions reported to Rs 1.35 crore in the quarter ended March 2026 as against net loss of Rs 7.35 crore during the previous quarter ended March 2025. Sales rose 94.34% to Rs 15.10 crore in the quarter ended March 2026 as against Rs 7.77 crore during the previous quarter ended March 2025.For the full year,net profit reported to Rs 3.08 crore in the year ended March 2026 as against net loss of Rs 7.67 crore during the previous year ended March 2025. Sales rose 72.57% to Rs 43.35 crore in the year ended March 2026 as against Rs 25.12 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales15.107.77 94 43.3525.12 73 OPM %2.85-80.69 -10.98-15.37 - PBDT0.59-6.54 LP 3.82-5.55 LP PBT0.05-7.21 LP 1.78-7.52 LP NP1.35-7.35 LP 3.08-7.67 LP Powered by Capital Market - Live News